Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report

BACKGROUND: Tirofiban is a nonpeptide glycoprotein IIb/IIIa receptor antagonist used widely in patients subjected to percutaneous coronary intervention. While the usage of tirofiban sets an important clinical benefit, severe thrombocytopenia can occur with use of this agent. CASE PRESENTATION: A 76-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ze-Mu, Wang, Bin, Li, Ya-Fei, Chen, Bei, Shen, Qin, Li, Dian-Fu, Wang, Lian-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576886/
https://www.ncbi.nlm.nih.gov/pubmed/37838704
http://dx.doi.org/10.1186/s13256-023-04169-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576886/
https://www.ncbi.nlm.nih.gov/pubmed/37838704
http://dx.doi.org/10.1186/s13256-023-04169-5

Ejemplares similares